ARCH THERAPEUTICS, INC. — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/40356cec-6d36-4507-afda-04ce1efa0bae/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-7.0M | 2022-10-01 – 2023-09-30 | evidence 0001437749-24-004234 |
| FY 2022 | $-5.3M | 2021-10-01 – 2022-09-30 | evidence 0001851734-22-000752 |
| FY 2021 | $-6.2M | 2020-10-01 – 2021-09-30 | evidence 0001410578-21-000550 |
| FY 2020 | $-4.7M | 2019-10-01 – 2020-09-30 | evidence 0001104659-20-134664 |
| FY 2019 | $-4.5M | 2018-10-01 – 2019-09-30 | evidence 0001104659-19-065500 |
| FY 2018 | $-4.8M | 2017-10-01 – 2018-09-30 | evidence 0001144204-18-065134 |
| FY 2017 | $-7.8M | 2016-10-01 – 2017-09-30 | evidence 0001144204-17-059213 |
| FY 2016 | $-6.0M | 2015-10-01 – 2016-09-30 | evidence 0001144204-16-137852 |
| FY 2015 | $-2.9M | 2014-10-01 – 2015-09-30 | evidence 0001144204-15-070409 |
| FY 2014 | $-8.1M | 2013-10-01 – 2014-09-30 | evidence 0001144204-14-073579 |
| FY 2013 | $-13.8M | 2006-03-06 – 2014-03-31 | evidence 0001144204-14-031168 |
| FY 2012 | $-47.5k | 2009-09-16 – 2013-03-31 | evidence 0001144204-13-030369 |
| FY 2011 | $-15.0k | 2009-09-16 – 2012-03-31 | evidence 0001165527-12-000396 |
| FY 2010 | $-420.1k | 2009-10-01 – 2010-09-30 | evidence 0001144204-13-069281 |
| FY 2009 | $-504.7k | 2008-10-01 – 2009-09-30 | evidence 0001144204-13-069281 |
| FY 2008 | $-233.0k | 2007-10-01 – 2008-09-30 | evidence 0001144204-13-069281 |
| FY 2007 | $-450.0k | 2006-10-01 – 2007-09-30 | evidence 0001144204-13-069281 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARCH THERAPEUTICS, INC. — all facts · Revenue · Operating Income